Growth Metrics

Trinity Biotech (TRIB) Long-Term Debt Repayments (2022)

Trinity Biotech's Long-Term Debt Repayments history spans 3 years, with the latest figure at -$23000.0 for Q4 2022.

  • On a quarterly basis, Long-Term Debt Repayments changed N/A to -$23000.0 in Q4 2022 year-over-year; TTM through Dec 2022 was -$27.3 million, a N/A change, with the full-year FY2022 number at -$23000.0, changed N/A from a year prior.
  • Long-Term Debt Repayments hit -$23000.0 in Q4 2022 for Trinity Biotech, up from -$194000.0 in the prior quarter.
  • Over the last five years, Long-Term Debt Repayments for TRIB hit a ceiling of -$23000.0 in Q4 2022 and a floor of -$23000.0 in Q4 2022.